{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:36:53Z","timestamp":1742949413736,"version":"3.40.3"},"publisher-location":"Cham","reference-count":122,"publisher":"Springer Nature Switzerland","isbn-type":[{"type":"print","value":"9783031612374"},{"type":"electronic","value":"9783031612381"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1007\/978-3-031-61238-1_11","type":"book-chapter","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T06:03:06Z","timestamp":1724997786000},"page":"207-232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Locoregional Therapies for Primary and Secondary Hepatic Malignancies"],"prefix":"10.1007","author":[{"given":"Muhamad","family":"Serhal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsun","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riad","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"key":"11_CR1","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","volume":"36","author":"HB El-Serag","year":"2002","unstructured":"El-Serag HB (2002) Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74-83","journal-title":"Hepatology"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12885-021-08138-3","volume":"21","author":"H Feng","year":"2021","unstructured":"Feng H, Li B, Li Z et al (2021) PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma. BMC Cancer 21:401","journal-title":"BMC Cancer"},{"key":"11_CR3","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJM199603143341104","volume":"334","author":"V Mazzaferro","year":"1996","unstructured":"Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693\u2013699","journal-title":"N Engl J Med"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","volume":"9","author":"RJ Lewandowski","year":"2009","unstructured":"Lewandowski RJ, Kulik LM, Riaz A et al (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Am J Transplant 9:1920\u20131928","journal-title":"Am J Transplant"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S et al (2018) Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391:1163\u20131173","journal-title":"Lancet"},{"key":"11_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M et al (2020) Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med 382:1894\u20131905","journal-title":"N Engl J Med"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(21)00604-5","volume":"23","author":"T Yau","year":"2022","unstructured":"Yau T, Park JW, Finn RS et al (2022) Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 23:77\u201390","journal-title":"Lancet Oncol"},{"key":"11_CR8","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1056\/NEJMoa0708857","volume":"359","author":"JM Llovet","year":"2008","unstructured":"Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390","journal-title":"N Engl J Med"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B et al (2021) Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol 6:17\u201329","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11_CR10","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2017.12.026","volume":"68","author":"C Spreafico","year":"2018","unstructured":"Spreafico C, Sposito C, Vaiani M et al (2018) Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion. J Hepatol 68:724\u2013732","journal-title":"J Hepatol"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00270-021-02800-w","volume":"44","author":"C Mosconi","year":"2021","unstructured":"Mosconi C, Solaini L, Vara G et al (2021) Transarterial chemoembolization and radioembolization for unresectable intrahepatic cholangiocarcinoma\u2014a systemic review and meta-analysis. Cardiovasc Intervent Radiol 44:728\u2013738","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2021.102258","volume":"99","author":"J Edeline","year":"2021","unstructured":"Edeline J, Lamarca A, McNamara MG et al (2021) Locoregional therapies in patients with intrahepatic cholangiocarcinoma: a systematic review and pooled analysis. Cancer Treat Rev 99:102258","journal-title":"Cancer Treat Rev"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1016\/j.ijrobp.2005.09.011","volume":"66","author":"JS Welsh","year":"2006","unstructured":"Welsh JS, Kennedy AS, Thomadsen B (2006) Selective Internal Radiation Therapy (SIRT) for liver metastases secondary to colorectal adenocarcinoma. Int J Radiat Oncol Biol Phys 66:S62-73","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1245\/s10434-014-4165-9","volume":"22","author":"R Hickey","year":"2015","unstructured":"Hickey R, Lewandowski R, Salem R (2015) Yttrium-90 radioembolization is a viable treatment option for unresectable, chemorefractory colorectal cancer liver metastases: further evidence in support of a new treatment paradigm. Ann Surg Oncol 22:706\u2013707","journal-title":"Ann Surg Oncol"},{"key":"11_CR15","doi-asserted-by":"crossref","unstructured":"Cazzato RL, Hubel\u00e9 F, De Marini P et al (2021) Liver-directed therapy for neuroendocrine metastases: from interventional radiology to nuclear medicine procedures. Cancers (Basel) 13","DOI":"10.3390\/cancers13246368"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jvir.2014.12.009","volume":"26","author":"H Mohan","year":"2015","unstructured":"Mohan H, Nicholson P, Winter DC et al (2015) Radiofrequency ablation for neuroendocrine liver metastases: a systematic review. J Vasc Interv Radiol 26:935-942.e1","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1089\/lap.2020.0558","volume":"31","author":"RC Pickens","year":"2021","unstructured":"Pickens RC, Sulzer JK, Passeri MJ et al (2021) Operative microwave ablation for the multimodal treatment of neuroendocrine liver metastases. J Laparoendosc Adv Surg Tech A 31:917\u2013925","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"11_CR18","doi-asserted-by":"crossref","unstructured":"Barat M, Cottereau AS, Kedra A et al (2020) The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review. J Clin Med 9","DOI":"10.3390\/jcm9072302"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejrad.2018.01.012","volume":"100","author":"Z Jia","year":"2018","unstructured":"Jia Z, Wang W (2018) Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: a systematic review. Eur J Radiol 100:23\u201329","journal-title":"Eur J Radiol"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1200\/JCO.2009.23.1282","volume":"27","author":"A Riaz","year":"2009","unstructured":"Riaz A, Ryu RK, Kulik LM et al (2009) Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival. J Clin Oncol 27:5734\u20135742","journal-title":"J Clin Oncol"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jvir.2008.05.002","volume":"19","author":"TK Rhee","year":"2008","unstructured":"Rhee TK, Naik NK, Deng J et al (2008) Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol 19:1180\u20131186","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR22","first-page":"644","volume":"95","author":"J Markowitz","year":"1952","unstructured":"Markowitz J (1952) The hepatic artery. Surg Gynecol Obstet 95:644\u2013646","journal-title":"Surg Gynecol Obstet"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nature04695","volume":"440","author":"JT Erler","year":"2006","unstructured":"Erler JT, Bennewith KL, Nicolau M et al (2006) Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222\u20131226","journal-title":"Nature"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1051-0443(98)70398-7","volume":"9","author":"KT Brown","year":"1998","unstructured":"Brown KT, Nevins AB, Getrajdman GI et al (1998) Particle embolization for hepatocellular carcinoma. J Vasc Interv Radiol 9:822\u2013828","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.2241011262","volume":"224","author":"C Camma","year":"2002","unstructured":"Camma C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47\u201354","journal-title":"Radiology"},{"key":"11_CR26","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1177\/2050640616673516","volume":"5","author":"A Facciorusso","year":"2017","unstructured":"Facciorusso A, Bellanti F, Villani R et al (2017) Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: a meta-analysis of randomized trials. United Eur Gastroenterol J 5:511\u2013518","journal-title":"United Eur Gastroenterol J"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1002\/hep.510270617","volume":"27","author":"J Bruix","year":"1998","unstructured":"Bruix J, Llovet JM, Castells A et al (1998) Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology 27:1578\u20131583","journal-title":"Hepatology"},{"key":"11_CR28","doi-asserted-by":"crossref","unstructured":"Maluccio MA, Covey AM, Porat LB et al (2008) Transcatheter arterial embolization with only particles for the treatment of unresectable hepatocellular carcinoma. J Vasc Interv Radiol (in press)","DOI":"10.1016\/j.jvir.2008.02.013"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/cncr.22191","volume":"107","author":"MA Maluccio","year":"2006","unstructured":"Maluccio MA, Covey AM, Schubert J et al (2006) Treatment of metastatic sarcoma to the liver with bland embolization. Cancer 107:1617\u20131623","journal-title":"Cancer"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1200\/JCO.2015.64.0821","volume":"34","author":"KT Brown","year":"2016","unstructured":"Brown KT, Do RK, Gonen M et al (2016) Randomized trial of hepatic artery embolization for hepatocellular carcinoma using doxorubicin-eluting microspheres compared with embolization with microspheres alone. J Clin Oncol 34:2046\u20132053","journal-title":"J Clin Oncol"},{"key":"11_CR31","doi-asserted-by":"crossref","unstructured":"Xia J, Ren Z, Ye S et al (2006) Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol","DOI":"10.1016\/j.ejrad.2006.03.002"},{"key":"11_CR32","doi-asserted-by":"crossref","unstructured":"Coldwell DM, Stokes KR, Yakes WF (1994) Embolotherapy: agents, clinical applications, and techniques. Radiographics 4:623\u2013643; quiz 645-6","DOI":"10.1148\/radiographics.14.3.8066276"},{"key":"11_CR33","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1053\/j.gastro.2006.05.021","volume":"131","author":"K Takayasu","year":"2006","unstructured":"Takayasu K, Arii S, Ikai I et al (2006) Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology 131:461\u2013469","journal-title":"Gastroenterology"},{"key":"11_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1200\/JCO.22.00392","volume":"41","author":"Z Peng","year":"2023","unstructured":"Peng Z, Fan W, Zhu B et al (2023) Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase III, randomized clinical trial (LAUNCH). J Clin Oncol 41:117\u2013127","journal-title":"J Clin Oncol"},{"key":"11_CR36","unstructured":"Geschwind J, Hong K, Georgiades C (2006) Utility of transcatheter arterial chemoembolization for liver dominant colorectal metastatic adenocarcinoma in the salvage setting. In: American Society of Clinical Oncology gastrointestinal cancers symposium. San Francisco, CA, 26\u201328 Jan 2006"},{"key":"11_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2214\/AJR.07.2550","volume":"190","author":"E Liapi","year":"2008","unstructured":"Liapi E, Geschwind J-F, Vossen JA et al (2008) Functional MRI evaluation of tumor response in patients with neuroendocrine hepatic metastasis treated with transcatheter arterial chemoembolization. Am J Roentgenol 190:67\u201373","journal-title":"Am J Roentgenol"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000463388","volume":"92","author":"H Okuyama","year":"2017","unstructured":"Okuyama H, Ikeda M, Takahashi H et al (2017) Transarterial (chemo)embolization for liver metastases in patients with neuroendocrine tumors. Oncology 92:353\u2013359","journal-title":"Oncology"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.breast.2017.09.001","volume":"36","author":"M Wang","year":"2017","unstructured":"Wang M, Zhang J, Ji S et al (2017) Transarterial chemoembolisation for breast cancer with liver metastasis: a systematic review. Breast 36:25\u201330","journal-title":"Breast"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/01.RVI.0000143768.60751.78","volume":"16","author":"I Burger","year":"2005","unstructured":"Burger I, Hong K, Schulick R et al (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16:353\u2013361","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1007\/s00270-007-9003-z","volume":"30","author":"T Murakami","year":"2007","unstructured":"Murakami T, Ishimaru H, Sakamoto I et al (2007) Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence. Cardiovasc Intervent Radiol 30:696\u2013704","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1001\/jama.299.14.1669","volume":"299","author":"BQ Cheng","year":"2008","unstructured":"Cheng BQ, Jia CQ, Liu CT et al (2008) Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA 299:1669\u20131677","journal-title":"JAMA"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1245\/s10434-008-0071-3","volume":"15","author":"JT Heckman","year":"2008","unstructured":"Heckman JT, Devera MB, Marsh JW et al (2008) Bridging locoregional therapy for hepatocellular carcinoma prior to liver transplantation. Ann Surg Oncol 15:3169\u20133177","journal-title":"Ann Surg Oncol"},{"key":"11_CR44","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1148\/radiology.197.3.7480761","volume":"197","author":"C Bartolozzi","year":"1995","unstructured":"Bartolozzi C, Lencioni R, Caramella D et al (1995) Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology 197:812\u2013818","journal-title":"Radiology"},{"key":"11_CR45","doi-asserted-by":"crossref","unstructured":"Shen L, Xi M, Zhao L et al (2018) Combination therapy after TACE for hepatocellular carcinoma with macroscopic vascular invasion: stereotactic body radiotherapy versus sorafenib. Cancers (Basel) 10","DOI":"10.3390\/cancers10120516"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00004836-200105000-00013","volume":"32","author":"HK Kim","year":"2001","unstructured":"Kim HK, Chung YH, Song BC et al (2001) Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma. J Clin Gastroenterol 32:423\u2013427","journal-title":"J Clin Gastroenterol"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s003300050159","volume":"7","author":"L Belli","year":"1997","unstructured":"Belli L, Magistretti G, Puricelli GP et al (1997) Arteritis following intra-arterial chemotherapy for liver tumors. Eur Radiol 7:323\u2013326","journal-title":"Eur Radiol"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/ncponc0512","volume":"3","author":"K Hong","year":"2006","unstructured":"Hong K, Georgiades CS, Geschwind JF (2006) Technology insight: Image-guided therapies for hepatocellular carcinoma\u2013intra-arterial and ablative techniques. Nat Clin Pract Oncol 3:315\u2013324","journal-title":"Nat Clin Pract Oncol"},{"key":"11_CR49","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.jhep.2006.10.020","volume":"46","author":"M Varela","year":"2007","unstructured":"Varela M, Real MI, Burrel M et al (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46:474\u2013481","journal-title":"J Hepatol"},{"key":"11_CR50","doi-asserted-by":"crossref","unstructured":"Constantin M, Fundueanu G, Bortolotti F et al (2004) Preparation and characterisation of poly(vinyl alcohol)\/cyclodextrin microspheres as matrix for inclusion and separation of drugs. Int J Pharm 285:87\u201396","DOI":"10.1016\/j.ijpharm.2004.07.025"},{"key":"11_CR51","doi-asserted-by":"crossref","unstructured":"Gonzalez MV, Tang Y, Phillips GJ et al (2007) Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro:in-vivo correlation. J Mater Sci Mater Med","DOI":"10.1007\/s10856-006-0040-y"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164\u20131171","journal-title":"Hepatology"},{"key":"11_CR53","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/bjc.2014.199","volume":"111","author":"R Golfieri","year":"2014","unstructured":"Golfieri R, Giampalma E, Renzulli M et al (2014) Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma. Br J Cancer 111:255\u2013264","journal-title":"Br J Cancer"},{"key":"11_CR54","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00330-016-4488-y","volume":"27","author":"A Monier","year":"2017","unstructured":"Monier A, Guiu B, Duran R et al (2017) Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion. Eur Radiol 27:1431\u20131439","journal-title":"Eur Radiol"},{"key":"11_CR55","doi-asserted-by":"crossref","unstructured":"Guiu B, Deschamps F, Aho S et al (2012) Liver\/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads. J Hepatol 56:609\u2013617","DOI":"10.1016\/j.jhep.2011.09.012"},{"key":"11_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejps.2006.09.002","volume":"30","author":"RR Taylor","year":"2007","unstructured":"Taylor RR, Tang Y, Gonzalez MV et al (2007) Irinotecan drug eluting beads for use in chemoembolization: in vitro and in vivo evaluation of drug release properties. Eur J Pharm Sci 30:7\u201314","journal-title":"Eur J Pharm Sci"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1148\/radiol.2242011283","volume":"224","author":"AM Covey","year":"2002","unstructured":"Covey AM, Brody LA, Maluccio MA et al (2002) Variant hepatic arterial anatomy revisited: digital subtraction angiography performed in 600 patients. Radiology 224:542\u2013547","journal-title":"Radiology"},{"key":"11_CR58","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jvir.2013.11.005","volume":"25","author":"VL Gates","year":"2014","unstructured":"Gates VL, Marshall KG, Salzig K et al (2014) Outpatient single-session yttrium-90 glass microsphere radioembolization. J Vasc Interv Radiol 25:266\u2013270","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR59","doi-asserted-by":"publisher","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","volume":"13","author":"R Salem","year":"2002","unstructured":"Salem R, Thurston KG, Carr BI et al (2002) Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13:S223\u2013S229","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR60","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jhep.2013.06.015","volume":"59","author":"M Vouche","year":"2013","unstructured":"Vouche M, Lewandowski RJ, Atassi R et al (2013) Radiation lobectomy: time-dependent analysis of future liver remnant volume in unresectable liver cancer as a bridge to resection. J Hepatol 59:1029\u20131036","journal-title":"J Hepatol"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","volume":"79","author":"A Riaz","year":"2011","unstructured":"Riaz A, Gates VL, Atassi B et al (2011) Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys 79:163\u2013171","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR62","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/jso.24269","volume":"114","author":"RJ Lewandowski","year":"2016","unstructured":"Lewandowski RJ, Donahue L, Chokechanachaisakul A et al (2016) (90) Y radiation lobectomy: outcomes following surgical resection in patients with hepatic tumors and small future liver remnant volumes. J Surg Oncol 114:99\u2013105","journal-title":"J Surg Oncol"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","volume":"74","author":"R Salem","year":"2021","unstructured":"Salem R, Johnson GE, Kim E et al (2021) Yttrium-90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study. Hepatology 74:2342\u20132352","journal-title":"Hepatology"},{"key":"11_CR64","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","volume":"7","author":"E Kim","year":"2022","unstructured":"Kim E, Sher A, Abboud G et al (2022) Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study. Lancet Gastroenterol Hepatol 7:843\u2013850","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jso.20609","volume":"94","author":"LM Kulik","year":"2006","unstructured":"Kulik LM, Atassi B, van Holsbeeck L et al (2006) Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94:572\u2013586","journal-title":"J Surg Oncol"},{"key":"11_CR66","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/hep.21980","volume":"47","author":"LM Kulik","year":"2007","unstructured":"Kulik LM, Carr BI, Mulcahy MF et al (2007) Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47:71\u201381","journal-title":"Hepatology"},{"key":"11_CR67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216935","volume":"14","author":"F Somma","year":"2019","unstructured":"Somma F, Stoia V, Serra N et al (2019) Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: the impact of portal vein thrombosis on survival. PLoS ONE 14:e0216935","journal-title":"PLoS ONE"},{"key":"11_CR68","doi-asserted-by":"crossref","unstructured":"Ibrahim SM, Mulcahy MF, Lewandowski RJ et al (2008) Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: results from a pilot study. Cancer","DOI":"10.1002\/cncr.23818"},{"key":"11_CR69","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","volume":"6","author":"J Edeline","year":"2020","unstructured":"Edeline J, Touchefeu Y, Guiu B et al (2020) Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial. JAMA Oncol 6:51\u201359","journal-title":"JAMA Oncol"},{"key":"11_CR70","unstructured":"Kennedy A, Coldwell D, Nutting C et al (2005) Liver brachytherapy for unresectable colorectal metastases: US results 2000\u20132004. In: ASCO GI symposium, Miami, FL, 27\u201329 Jan 2005"},{"key":"11_CR71","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1200\/JCO.2008.20.8116","volume":"27","author":"GA van Hazel","year":"2009","unstructured":"van Hazel GA, Pavlakis N, Goldstein D et al (2009) Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy. J Clin Oncol 27:4089\u20134095","journal-title":"J Clin Oncol"},{"key":"11_CR72","doi-asserted-by":"crossref","unstructured":"Gray B, Van Hazel G, Hope M et al (2001) Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12:1711\u20131720","DOI":"10.1023\/A:1013569329846"},{"key":"11_CR73","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1200\/JCO.2015.66.1181","volume":"34","author":"GA van Hazel","year":"2016","unstructured":"van Hazel GA, Heinemann V, Sharma NK et al (2016) SIRFLOX: randomized phase III trial comparing first-line mFOLFOX6 (plus or minus bevacizumab) versus mFOLFOX6 (plus or minus bevacizumab) plus selective internal radiation therapy in patients with metastatic colorectal cancer. J Clin Oncol 34:1723\u20131731","journal-title":"J Clin Oncol"},{"key":"11_CR74","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1200\/JCO.21.01839","volume":"39","author":"MF Mulcahy","year":"2021","unstructured":"Mulcahy MF, Mahvash A, Pracht M et al (2021) Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial. J Clin Oncol 39:3897\u20133907","journal-title":"J Clin Oncol"},{"key":"11_CR75","first-page":"216","volume":"2","author":"JE Goin","year":"2003","unstructured":"Goin JE, Dancey JE, Hermann GA et al (2003) Treatment of unresectable metastatic colorectal carcinoma to the liver with intrahepatic Y-90 microspheres: a dose-ranging study. World J of Nuc Med 2:216\u2013225","journal-title":"World J of Nuc Med"},{"key":"11_CR76","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/SLA.0b013e3181728a45","volume":"247","author":"TK Rhee","year":"2008","unstructured":"Rhee TK, Lewandowski RJ, Liu DM et al (2008) 90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience. Ann Surg 247:1029\u20131035","journal-title":"Ann Surg"},{"key":"11_CR77","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/COC.0b013e31815e4557","volume":"31","author":"AS Kennedy","year":"2008","unstructured":"Kennedy AS, Dezarn WA, McNeillie P et al (2008) Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients. Am J Clin Oncol 31:271\u2013279","journal-title":"Am J Clin Oncol"},{"key":"11_CR78","unstructured":"Coldwell D, Nutting C, Kennedy AK (2005) Treatment of hepatic metastases from breast cancer with Yttrium-90 SIR-Spheres radioembolization. In: Society of Interventional Radiology annual meeting, New Orleans, LA, 31 Mar 31\u20135 Apr 2005"},{"key":"11_CR79","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jvir.2016.05.028","volume":"27","author":"CC Pieper","year":"2016","unstructured":"Pieper CC, Meyer C, Wilhelm KE et al (2016) Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases-a single-center experience. J Vasc Interv Radiol 27:1305\u20131315","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR80","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1148\/radiol.2472062029","volume":"247","author":"KT Sato","year":"2008","unstructured":"Sato KT, Lewandowski RJ, Mulcahy MF et al (2008) Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres\u2013safety, efficacy, and survival. Radiology 247:507\u2013515","journal-title":"Radiology"},{"key":"11_CR81","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1097\/01.RVI.0000184594.01661.81","volume":"16","author":"R Salem","year":"2005","unstructured":"Salem R, Lewandowski RJ, Atassi B et al (2005) Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol 16:1627\u20131639","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR82","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","volume":"65","author":"AS Kennedy","year":"2006","unstructured":"Kennedy AS, Coldwell D, Nutting C et al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65:412\u2013425","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR83","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1097\/01.RVI.0000161142.12822.66","volume":"16","author":"R Murthy","year":"2005","unstructured":"Murthy R, Xiong H, Nunez R et al (2005) Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results. J Vasc Interv Radiol 16:937\u2013945","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR84","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1002\/cncr.23339","volume":"112","author":"B Sangro","year":"2008","unstructured":"Sangro B, Gil-Alzugaray B, Rodriguez J et al (2008) Liver disease induced by radioembolization of liver tumors: description and possible risk factors. Cancer 112:1538\u20131546","journal-title":"Cancer"},{"key":"11_CR85","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.jvir.2007.07.016","volume":"18","author":"JY Young","year":"2007","unstructured":"Young JY, Rhee TK, Atassi B et al (2007) Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma. J Vasc Interv Radiol 18:1375\u20131382","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR86","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1007\/s10620-007-0148-z","volume":"53","author":"TF Jakobs","year":"2008","unstructured":"Jakobs TF, Saleem S, Atassi B et al (2008) Fibrosis, portal hypertension, and hepatic volume changes induced by intra-arterial radiotherapy with (90)yttrium microspheres. Dig Dis Sci 53:2556\u20132563","journal-title":"Dig Dis Sci"},{"key":"11_CR87","unstructured":"TheraSphere Yttrium-90 microspheres package insert, MDS Nordion, Kanata, Canada (2004)"},{"key":"11_CR88","doi-asserted-by":"crossref","unstructured":"Murthy R, Brown DB, Salem R et al (2007) Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol 18:553\u2013561 (quiz 562)","DOI":"10.1016\/j.jvir.2007.02.002"},{"key":"11_CR89","doi-asserted-by":"crossref","unstructured":"Carretero C, Munoz-Navas M, Betes M et al (2007) Gastroduodenal injury after radioembolization of hepatic tumors. Am J Gastroenterol","DOI":"10.1111\/j.1572-0241.2007.01172.x"},{"key":"11_CR90","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1016\/j.jvir.2007.08.015","volume":"18","author":"R Murthy","year":"2007","unstructured":"Murthy R, Eng C, Krishnan S et al (2007) Hepatic yttrium-90 radioembolotherapy in metastatic colorectal cancer treated with cetuximab or bevacizumab. J Vasc Interv Radiol 18:1588\u20131591","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR91","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1053\/j.tvir.2007.08.006","volume":"10","author":"R Lencioni","year":"2007","unstructured":"Lencioni R, Crocetti L (2007) Radiofrequency ablation of liver cancer. Tech Vasc Interv Radiol 10:38\u201346","journal-title":"Tech Vasc Interv Radiol"},{"key":"11_CR92","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2214\/ajr.173.5.10541093","volume":"173","author":"S Sironi","year":"1999","unstructured":"Sironi S, Livraghi T, Meloni F et al (1999) Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol 173:1225\u20131229","journal-title":"AJR Am J Roentgenol"},{"key":"11_CR93","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1148\/radiol.2353042205","volume":"235","author":"SN Goldberg","year":"2005","unstructured":"Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728\u2013739","journal-title":"Radiology"},{"key":"11_CR94","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.3748\/wjg.v22.i10.2993","volume":"22","author":"W Yang","year":"2016","unstructured":"Yang W, Yan K, Goldberg SN et al (2016) Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 22:2993\u20133005","journal-title":"World J Gastroenterol"},{"key":"11_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.surg.2007.01.036","volume":"142","author":"PJ Mazzaglia","year":"2007","unstructured":"Mazzaglia PJ, Berber E, Milas M et al (2007) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142:10\u201319","journal-title":"Surgery"},{"key":"11_CR96","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1148\/radiol.2361040533","volume":"236","author":"SA Shock","year":"2005","unstructured":"Shock SA, Laeseke PF, Sampson LA et al (2005) Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology 236:125\u2013131","journal-title":"Radiology"},{"key":"11_CR97","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1053\/j.tvir.2007.08.005","volume":"10","author":"JL Hinshaw","year":"2007","unstructured":"Hinshaw JL, Lee FT Jr (2007) Cryoablation for liver cancer. Tech Vasc Interv Radiol 10:47\u201357","journal-title":"Tech Vasc Interv Radiol"},{"key":"11_CR98","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1097\/01.RVI.0000170858.46668.65","volume":"16","author":"SN Goldberg","year":"2005","unstructured":"Goldberg SN, Grassi CJ, Cardella JF et al (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 16:765\u2013778","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR99","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2214\/ajr.185.1.01850051","volume":"185","author":"GD Dodd 3rd","year":"2005","unstructured":"Dodd GD 3rd, Napier D, Schoolfield JD et al (2005) Percutaneous radiofrequency ablation of hepatic tumors: postablation syndrome. AJR Am J Roentgenol 185:51\u201357","journal-title":"AJR Am J Roentgenol"},{"key":"11_CR100","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1109\/10.930907","volume":"48","author":"P Liang","year":"2001","unstructured":"Liang P, Dong B, Yu X et al (2001) Computer-aided dynamic simulation of microwave-induced thermal distribution in coagulation of liver cancer. IEEE Trans Biomed Eng 48:821\u2013829","journal-title":"IEEE Trans Biomed Eng"},{"key":"11_CR101","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.2214\/ajr.180.6.1801547","volume":"180","author":"B Dong","year":"2003","unstructured":"Dong B, Liang P, Yu X et al (2003) Percutaneous sonographically guided microwave coagulation therapy for hepatocellular carcinoma: results in 234 patients. AJR Am J Roentgenol 180:1547\u20131555","journal-title":"AJR Am J Roentgenol"},{"key":"11_CR102","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jvir.2006.10.005","volume":"18","author":"IR Kamel","year":"2007","unstructured":"Kamel IR, Reyes DK, Liapi E et al (2007) Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 18:49\u201356","journal-title":"J Vasc Interv Radiol"},{"key":"11_CR103","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1148\/radiol.2232010775","volume":"223","author":"T Shibata","year":"2002","unstructured":"Shibata T, Iimuro Y, Yamamoto Y et al (2002) Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 223:331\u2013337","journal-title":"Radiology"},{"key":"11_CR104","doi-asserted-by":"crossref","unstructured":"Facciorusso A, Abd El Aziz MA, Tartaglia N et al (2020) Microwave ablation versus radiofrequency ablation for treatment of hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Cancers (Basel) 12","DOI":"10.3390\/cancers12123796"},{"key":"11_CR105","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0169-5002(00)00241-5","volume":"33","author":"H Nakamura","year":"2001","unstructured":"Nakamura H, Kawasaki N, Hagiwara M et al (2001) Early hilar lung cancer\u2013risk for multiple lung cancers and clinical outcome. Lung Cancer 33:51\u201357","journal-title":"Lung Cancer"},{"key":"11_CR106","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41598-021-03802-x","volume":"12","author":"A Radosevic","year":"2022","unstructured":"Radosevic A, Quesada R, Serlavos C et al (2022) Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial. Sci Rep 12:316","journal-title":"Sci Rep"},{"key":"11_CR107","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1148\/radiology.219.3.r01ma02669","volume":"219","author":"CM Pacella","year":"2001","unstructured":"Pacella CM, Bizzarri G, Cecconi P et al (2001) Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization. Radiology 219:669\u2013678","journal-title":"Radiology"},{"key":"11_CR108","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1148\/radiology.187.2.8475269","volume":"187","author":"CP Nolsoe","year":"1993","unstructured":"Nolsoe CP, Torp-Pedersen S, Burcharth F et al (1993) Interstitial hyperthermia of colorectal liver metastases with a US-guided Nd-YAG laser with a diffuser tip: a pilot clinical study. Radiology 187:333\u2013337","journal-title":"Radiology"},{"key":"11_CR109","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00432-006-0138-0","volume":"132","author":"TJ Vogl","year":"2006","unstructured":"Vogl TJ, Schwarz W, Eichler K et al (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132:745\u2013755","journal-title":"J Cancer Res Clin Oncol"},{"key":"11_CR110","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1148\/radiol.2332030454","volume":"233","author":"MG Mack","year":"2004","unstructured":"Mack MG, Straub R, Eichler K et al (2004) Breast cancer metastases in liver: laser-induced interstitial thermotherapy\u2013local tumor control rate and survival data. Radiology 233:400\u2013409","journal-title":"Radiology"},{"key":"11_CR111","doi-asserted-by":"crossref","unstructured":"Delabrousse E, Mithieux F, Birer A et al (2008) Percutaneous sonographically guided interstitial US ablation: experimentation in an in vivo pig liver model. J Vasc Interv Radiol","DOI":"10.1016\/j.jvir.2008.09.018"},{"key":"11_CR112","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhu H, Jin C et al (2008) High-intensity focused ultrasound (HIFU): effective and safe therapy for hepatocellular carcinoma adjacent to major hepatic veins. Eur Radiol","DOI":"10.1007\/s00330-008-1137-0"},{"key":"11_CR113","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1148\/radiol.2352030916","volume":"235","author":"F Wu","year":"2005","unstructured":"Wu F, Wang ZB, Chen WZ et al (2005) Advanced hepatocellular carcinoma: treatment with high-intensity focused ultrasound ablation combined with transcatheter arterial embolization. Radiology 235:659\u2013667","journal-title":"Radiology"},{"key":"11_CR114","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00270-004-4082-6","volume":"28","author":"TD Atwell","year":"2005","unstructured":"Atwell TD, Charboneau JW, Que FG et al (2005) Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques. Cardiovasc Intervent Radiol 28:409\u2013421","journal-title":"Cardiovasc Intervent Radiol"},{"key":"11_CR115","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1148\/radiol.2481061874","volume":"248","author":"RT Nair","year":"2008","unstructured":"Nair RT, Silverman SG, Tuncali K et al (2008) Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures. Radiology 248:303\u2013311","journal-title":"Radiology"},{"key":"11_CR116","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1756-9966-27-28","volume":"27","author":"EM Zardi","year":"2008","unstructured":"Zardi EM, Di Matteo F, Santini D et al (2008) Pancreatitis after percutaneous ethanol injection into HCC: a minireview of the literature. J Exp Clin Cancer Res 27:28","journal-title":"J Exp Clin Cancer Res"},{"key":"11_CR117","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1148\/radiol.2281020718","volume":"228","author":"RA Lencioni","year":"2003","unstructured":"Lencioni RA, Allgaier HP, Cioni D et al (2003) Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 228:235\u2013240","journal-title":"Radiology"},{"key":"11_CR118","doi-asserted-by":"crossref","unstructured":"Di Stasi M, Buscarini L, Livraghi T et al (1997) Percutaneous ethanol injection in the treatment of hepatocellular carcinoma. A multicenter survey of evaluation practices and complication rates. Scand J Gastroenterol 32:1168\u20131173","DOI":"10.3109\/00365529709002998"},{"key":"11_CR119","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1148\/radiology.193.3.7972818","volume":"193","author":"K Ohnishi","year":"1994","unstructured":"Ohnishi K, Ohyama N, Ito S et al (1994) Small hepatocellular carcinoma: treatment with US-guided intratumoral injection of acetic acid. Radiology 193:747\u2013752","journal-title":"Radiology"},{"key":"11_CR120","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/hep.510270112","volume":"27","author":"K Ohnishi","year":"1998","unstructured":"Ohnishi K, Yoshioka H, Ito S et al (1998) Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 27:67\u201372","journal-title":"Hepatology"},{"key":"11_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/153303460700600106","volume":"6","author":"B Rubinsky","year":"2007","unstructured":"Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality\u2013clinical implications. Technol Cancer Res Treat 6:37\u201348","journal-title":"Technol Cancer Res Treat"},{"key":"11_CR122","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/jso.23280","volume":"107","author":"R Cannon","year":"2013","unstructured":"Cannon R, Ellis S, Hayes D et al (2013) Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol 107:544\u2013549","journal-title":"J Surg Oncol"}],"container-title":["Cancer Treatment and Research","Gastrointestinal Malignancies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-031-61238-1_11","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T14:02:08Z","timestamp":1732716128000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-031-61238-1_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9783031612374","9783031612381"],"references-count":122,"URL":"https:\/\/doi.org\/10.1007\/978-3-031-61238-1_11","relation":{},"ISSN":["0927-3042","2509-8497"],"issn-type":[{"type":"print","value":"0927-3042"},{"type":"electronic","value":"2509-8497"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"31 August 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}